Скачать или смотреть A real-world analysis of CNS involvement in CLL

Jacob Soumerai, MD, Massachusetts General Hospital, Boston, MA, comments on the rarity of central nervous system (CNS) involvement in chronic lymphocytic leukemia (CLL), noting that it has an incidence of as low as 0.5 to 1%. Dr Soumerai emphasizes that CNS involvement can occur in both patients with treatment-naive and relapsed/refractory disease, and that novel agents appear to be active and efficacious in this patient population. This interview took place at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2025 in Krakow, Poland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.